Skip to main content

Stemtech Corp

corporate_fare Company Profile

Stemtech Corp

STEK·OTC·Trade & Services·CIK 0000934851

Stemtech Corp is a stem cell nutrition company that develops science-based products designed to help the body maintain healthy stem cell physiology. The company's products aim to enhance and support the work of the body's stem cells by releasing more stem cells, aiding their circulation in the blood, and facilitating their migration into tissues. This process supports the daily function of renewal for optimal health. Stemtech Corp offers several products, including rapid renew stem cell peptide night cream, which is part of the RCM System. Other brand names include stemrelease3, Stemflo MigraStem, and OraStem. The company also provides Collect One, and Cellect One shield hypochlorous acid skin care product. Stemtech Corp distributes its products through independent distributors. The company operates in the Americas, Latin America, and Asia. Founded in 2005, Stemtech Corp is headquartered in Naples, Florida.

Stemtech Corp (OTC:STEK) is a publicly traded company in the Trade & Services sector. Wiseek monitors STEK SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • Stemtech Q1 Revenue Drops 47% to $463K, Net Loss Narrows Despite Sales Decline
  • Stemtech Reports Q1 Loss Amid 450% Share Dilution, Going Concern Warning, and Control Weaknesses
  • Stemtech Revenue Plunges 43% to $2.88M in FY25 Amid Supply Issues
  • Stemtech Corp Reports 43% Revenue Decline, Widening Losses, Going Concern Warning, and Massive Dilution

Dilution Risk

Low risk

Filing-implied dilution signals for STEK, detected from its recent SEC filings · latest filing 2026-06-22.

Massive Share Dilution · Continued Going Concern Warning

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with S →
$0.000096 -0.00% today
52-week range · as of 2026-06-22 $0.000096 – $0.0346
Market cap
$216.93K
Volume
15.8M (0.3× avg)
3-mo avg 54.9M
Live data · 2026-07-14 00:49 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed STEK - Latest Insights

STEK
Jun 22, 2026, 4:41 PM EDT
Source: Wiseek News
Importance Score:
8
Stemtech Q1 Revenue Drops 47% to $463K, Net Loss Narrows Despite Sales Decline
Price at Filing: $0.0001
Real-time Price: $0.000096 info
Change: -$0.000004 (-4%) info
Market Cap: $216.929K info
Sentiment: Neutral
View Wiseek Article
STEK
Jun 22, 2026, 4:33 PM EDT
Filing Type: 10-Q
Importance Score:
9
Stemtech Reports Q1 Loss Amid 450% Share Dilution, Going Concern Warning, and Control Weaknesses
Price at Filing: $0.0001
Real-time Price: $0.000096 info
Change: -$0.000004 (-4%) info
Market Cap: $216.929K info
Sentiment: Negative
View Wiseek Article
STEK
May 29, 2026, 5:05 PM EDT
Source: Wiseek News
Importance Score:
8
Stemtech Revenue Plunges 43% to $2.88M in FY25 Amid Supply Issues
Price at Filing: $0.0002
Real-time Price: $0.000096 info
Change: -$0.000104 (-52%) info
Market Cap: $216.929K info
Sentiment: Negative
View Wiseek Article
STEK
May 29, 2026, 4:58 PM EDT
Filing Type: 10-K
Importance Score:
9
Stemtech Corp Reports 43% Revenue Decline, Widening Losses, Going Concern Warning, and Massive Dilution
Price at Filing: $0.0002
Real-time Price: $0.000096 info
Change: -$0.000104 (-52%) info
Market Cap: $216.929K info
Sentiment: Negative
View Wiseek Article